Joe Jimenez to replace Daniel Vasella as Novartis CEO

> Joe Jimenez to replace Daniel Vasella as Novartis CEO. Release
> Afferent Pharmaceuticals has appointed Bruce McCarthy as CEO.
> Pavan Handa has joined Antares Pharma as SVP of business development.
> Array BioPharma has announced that Bengt Bergstrom has joined the company as VP of clinical development.
> Shionogi Pharma has announced that Ray Russo has joined the company as VP, primary care business unit.
> Constellation Pharmaceuticals has tapped Garen Bohlin as the company's EVP. Bohlin will be responsible for Constellation's corporate operations and finance function.
> Lauren Sabella has joined Acorda Therapeutics as EVP, commercial development. Sabella will have responsibility for Acorda's commercial operations, including marketing, sales and managed markets.
> Malcolm MacCoss has been elected to Idera Pharmaceuticals' board of directors as a class II director.
> ProtoKinetix has appointed John Hutton to its scientific advisory board.

Add new comment

Images
More information
  • Files must be less than 2 MB.
  • Allowed file types: png gif jpg jpeg.
Documents
More information
  • Files must be less than 2 MB.
  • Allowed file types: zip rar.